Page 442 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 442

430        FLUID THERAPY


            hemoglobin on nitric oxide. This effect may be of benefit  POSTOPERATIVE FLUID
            in some severely hypotensive and hypovolemic patients in  MANAGEMENT
            which an immediate increase in blood pressure would be
            desirable.Oxyglobinalsowouldbeveryusefulinananimal   The patient will continue to lose fluids over time and may
            that fails to crossmatch to existing donors and yet needs  have decreased food and water intake after surgery. Con-
            increased oxygen-carrying capacity intraoperatively. 46  sequently, it is essential to consider fluid therapy in the
            Experimentally, it has been shown that Oxyglobin results  postoperative period. The choice of fluid is governed
            in a more rapid increase in muscle tissue oxygenation than  by factors similar to those used before and during surgery.
            occurs with the infusion of a similar dose of stored packed  A main factor to consider is when the animal is likely to be
            cells. 174  Thisobservationsuggeststhatanimalswithsevere  able to regulate its own fluid balance. With minor surgical
            shock, anemia, orischemia may benefit from an infusion of  procedures, this may be almost immediately after surgery,
            Oxyglobin as an initial treatment that could then be  but with procedures in which recovery is slow or oral
            followed by more Oxyglobin or the use of blood products.  intake is contraindicated, it is necessary to continue fluid
                                                                 therapy. Continuing fluid therapy may be particularly
            CRYSTALLOIDS VERSUS                                  important in geriatric patients because they often are
            COLLOIDS                                             unwilling to drink in the hospital environment and may
                                                                 be at greater risk because of marginal renal function.
            There has been a long debate over the nature of the fluid
            that should be used for volume expansion. In the human
            medical literature, this question has been addressed in a  REFERENCES
            number of reviews. The most recent review in the
            Cochrane database for the use of crystalloids or colloids  1. Aarnes TK, Bednarski RM, Lerche P, et al. Effect of intra-
            in critically ill patients states, “There is no evidence from  venous administration of lactated Ringer’s solution or
                                                                     hetastarch for the treatment of isoflurane-induced hypo-
            random controlled trials (RCTs) that resuscitation with  tension in dogs. Am J Vet Res 2009;70:1345–53.
            colloids reduces the risk of death, compared to resuscita-  2. Abbott TR. Changes in serum calcium fractions and cit-
            tion with crystalloids, in patients with trauma, burns or  rate concentrations during massive blood transfusions
            following surgery.” As colloids are not associated with  and   cardiopulmonary  bypass.  Br  J  Anaesth
                                                                     1983;55:753–9.
            an improvement in survival, and as they are more expen-
                                                                   3. Adrogue HJ, Tannen RL. Ketoacidosis, hyperosmolar
            sive than crystalloids, it is hard to see how their continued
                                                                     states, and lactic acidosis. In: Kokko JP, Tannen RL,
            use in these patients can be justified outside the context of  editors. Fluids and Electrolytes. 3rd ed Philadelphia:
            RCTs. 137  In isoflurane-induced hypotension (80 mm Hg   W.B. Saunders; 1996. p. 643–74.
            systolic arterial blood pressure [SAP]) in dogs, an HES  4. Akanji AO, Bruce MA, Frayn KN. Effect of acetate infu-
                                                                     sion on energy expenditure and substrate oxidation rates
            (6% HES 450) infusion of 40 mL/kg restored blood
                                                                     in non-diabetic and diabetic subjects. Eur J Clin Nutr
            pressure in 4 of 6 animals but 80 mL/kg LRS did not      1989;43:107–15.
                                         1
            successfully resuscitate any animal. In dogs made hypo-  5. Allard RL, Carlos AD, Faltin EC. Canine hematological
            tensive (80 mm Hg SAP) by blood loss, restoration of     changes during gestation and lactation. Companion Ani-
            blood pressure to within 10% of control took 194 mL      mal Practice 1989;19:3–6.
                                                                   6. Allon M, Copkney C. Albuterol and insulin for treatment
            of HES as compared with 749 mL of LRS. In the former
                                                                     of hyperkalemia in hemodialysis patients. Kidney Int
            experiment, the authors concluded that HES should be     1990;38:869–72.
            used rather than LRS to treat isoflurane-induced hypo-  7. Anand IS, Ferrari R, Kalra GS, et al. Edema of cardiac ori-
            tension. However, in neither of these experiments were   gin. Studies of body water and sodium, renal function,
            the cardiac indices different between treatments,        hemodynamic indexes, and plasma hormones in untreated
                                                                     congestive cardiac failure. Circulation 1989;80:299–305.
            suggesting that both solutions restored systemic blood  8. Asao Y, Hirasaki A, Matsushita M, et al. A patient who
            flow. In the isoflurane experiment, oxygen delivery was  recovered  successfully  from  severe  anemia  which
            no   different  between  treatments  either,  further    continued for one hour. Masui 1997;46:700–3.
            supporting the notion that blood pressure is not a partic-  9. Baer RW, Vlahakes GJ, Uhlig PN, et al. Maximum
            ularly good goal for therapy. 129  Colloidal solutions   myocardial oxygen transport during anemia and polycy-
            should increase vascular volume faster and for a longer  themia in dogs. Am J Physiol 1987;252:H1086–H1095.
                                                                  10. Baraff LJ. Capillary refill: Is it a useful clinical sign? Pedi-
            period of time than crystalloids, and therefore may be
                                                                     atrics 1993;92:723–4.
            useful when colloid osmotic pressure is low or when   11. Barron ME, Wilkes MM, Navickis RJ. A systematic review
            crystalloids are not working well because their effect is  of the comparative safety of colloids. Arch Surg
            transient. However, given the evidence cited above, use  2004;139:552–63.
                                                                  12. Bennett-Guerrero E, Kahn RA, Moskowitz DM, et al.
            of crystalloids as a primary form of fluid therapy still
                                                                     Comparison of arterial systolic pressure variation with
            seems justified with the addition of colloids when neces-
                                                                     other clinical parameters to predict the response to fluid
            sary to improve COP, oxygen delivery, or to prolong the  challenges during cardiac surgery. Mt Sinai J Med
            achieved increase in circulating volume.                 2002;69:96–100.
   437   438   439   440   441   442   443   444   445   446   447